维普中文期刊产品整合服务
248篇 您的检索式:作者名="Paesmans"
    题名 作者 年代 出处 被引量
1E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells显示文摘Jan Theys Barry Jutten Roger Habets Kim Paesmans Arjan J. Groot Philippe Lambin Brad G. Wouters Guido Lammering Marc Vooijs 2011Radiotherapy and Oncology2011,,3:3
2The role of HER-2/neu expression on the survival of patients with lung cancer:a systematic review of the literature显示文摘Meert AP Martin B Paesmans M 2003Br J Cancer2003,89,6:1
3Survival improvement in resectable non - small cell lung cancer with ( neo ) adjuvant chemotherapy:results of a meta - analysis of the literature 显示文摘Berghmans T Paesmans M Meert AP 2005Lung Cancer2005,49,1:1
4A prospective study on hyponatraemia in medical cancer patients :epidemiology, aetiology and differential diagnosis 显示文摘Berghmans T Paesmans M Body J J 2000Support Care Cancer2000,8,3:1
5Ki67 expression and patients survival in lug cancer: systematic review of the literature with meta-analysis显示文摘Martin B Paesmans M Mascaux C 2004BrJ Cancer2004,91,12:1
6Role of Bcl-2 as a prog nostic factor for survival in lung cancer : A systematic review of the literature with meta-analysis显示文摘Martin B Paesmans M Berghmans T 2003Br J Cancer2003,89,:1
7The role of HER-2/neu expression on the survival of patients with lung cancer:a systematic review of the literature显示文摘Meert AP Martin B Paesmans M 2003Br J Cancer2003,89,6:1
8Correlation between topoisomerase-Ⅱ alpha gene amplification and protein expression in HER-2 amplified breast cancer显示文摘Durbecq V Desmed C Paesmans M 2004Int J Oncol2004,25,5:1
9Topoisomerase-II alpha expression as a predictive marker in a populationof advanced breast cancer patients randomly treated eitherwith single-agent doxorubicin or single-agent docetaxel显示文摘Durbecq V Paesmans M Cardoso F 2004Mol Cancer Ther2004,3,10:1
10A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer显示文摘Sculier JP Paesmans M Thiriaux J 1999Eur J Cancer1999,35,9:1
11Activity of chemo-therapy and immunotherapy on malignant mesothelioma: a sys-tematic review of the literature with meta-analysis 显示文摘Berghmans T Paesmans M Lalami Y 2002LungCancer2002,38,2:1
12The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients 显示文摘Klastersky J Paesmans M 2013Surport Care Caneer2013,21,5:1
13A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis显示文摘T. Berghmans M. Paesmans J.-J. Body 2000Supportive Care Cancer2000,,3:1
14A prospective study on hyponatraemia in medical cancer patients:epidemiology, aetiology and differential dignosis显示文摘Berghmans T Paesmans M Body JJ 2000Support Care Cancer2000,8,3:1
15Expression of thrombospondin in non-small cell lung cancer显示文摘Mascaux C Martin B Paesmans M 2002Anticancer Res2002,22,2:1
16Imipenem versus targetedtherapyin cancer patients显示文摘Aoun M Crokaert F Paesmans M 1998Int J Antimicrob Agents1998,10,4:1
17Role of Bcl-2 as a prognostic factor for survival in lung cancer:a systematic review of the literature with meta-analysis显示文摘Martin B Paesmans M Berghmans T 2003BrJ Cancer2003,89,1:1
18Prognostic factors in stage III non-small cell lung cancer : a review of conventional, metabolic and new biological variables 显示文摘Berghmans T Paesmans M Sculier JP 2011Therapeutic Advances in Medical Oncology2011,3,3:1
19Prognostic factors for patients with small cell lung carcinoma:analysis of a serics of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years显示文摘Paesmans M Sculier JP Lecomte J 0,,:1
20A prospective study on hyponatraemia in medical cancer patients : epidemiology, aetiology and differential diagnosis 显示文摘Berghmans T Paesmans T Body JJ 2000Support Care Cancer2000,8,3:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费